SCRS Adds PRA Health Sciences as Global Impact Partner
The Society for Clinical Research Sites (SCRS), a global trade organization representing the interests of clinical research sites, announced a two-year partnership with PRA Health Sciences.
The Society for Clinical Research Sites (SCRS), a global trade organization representing the interests of clinical research sites, announced a two-year partnership with PRA Health Sciences (PRA). PRA will participate as a Global Impact Partner (GIP), where the CRO participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council in the development and execution of strategic initiatives for SCRS.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
How the NIMBLE Study Supported Adherence With Quarterly Dosing of CemdisiranSeptember 18th 2025
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
